Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Other Financing Activities

Financing cash flows not reported separately.

No reported Other Financing Activities figures are available to summarize.

Other Financing Activities history

Currency unavailable · from the cash flow

No Other Financing Activities data reported for this period type.

Other Financing Activities vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Other Financing Activities for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$303.49M USD———
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$19.65M USD+476.3%——
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$12.47M USD+463.5%——
GHRSGH Research PLCLTM Mar 2026$5.6M USD-38.7%——
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$210K USD-174.2%—1.1%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$104K USD+333.3%——
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$0 USD+100.0%—0.0%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+216.7%—0.5%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.